PRISM MediaWire

Artificial Intelligence:

Advancements in Artificial Intelligence Enhance Travel Experience in 2024: TSA Precheck and Airlines Introduce "Touchless ID" System; BBAI Stock Surges Approximately 30% Following Announcement of "Vision AI" Acquisition

New York, March 04, 2024 - PRISM MediaWire - United Airlines (UA) is set to introduce "Touchless ID" technology, replacing traditional boarding passes and IDs for passengers traveling through Chicago O'Hare and Los Angeles International airports. The program is slated fo...

4 March 2024

NeuroBo Pharmaceuticals to Commence Clinical Trial Addressing Obesity

New York, March 04, 2024 - PRISM MediaWire - NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) has obtained Institutional Review Board (IRB) approval to advance its Phase 1 clinical trial of DA-1726, targeting obesity treatment. Anticipated commencement of patient randomizati...

4 March 2024

Lexaria to Progress CBD Hypertension Candidate Following IND Approval

New York, March 01, 2024 - PRISM MediaWire - Lexaria Bioscience (Nasdaq: LEXX) has made significant strides in advancing its CBD-based candidate for hypertension, marked by the recent clearance of its investigational new drug (IND) application by the FDA. With this regul...

1 March 2024

Electric Vehicles

Exploring AI Integration in Electric Vehicles: Indie Semiconductor (INDI) Forges Ahead, Achieves Electrifying Earnings, Establishes Strategic AI Partnership

New York, N.Y., February 29, 2024 - PRISM MediaWire - Indie Semiconductor, Inc. (INDI), renowned for its automotive software solutions and semiconductor expertise, has significantly propelled the advancement of vehicle electrification. In its recent report on Q4 earnings...

1 March 2024

Medical Devices

Establishment Labs Holdings (ESTA) Nearly Doubles Share Price Following Debut on PRISM Women’s Health Index Two Months Ago

New York, N.Y., February 29, 2024 - PRISM MediaWire - Establishment Labs Holdings Inc. (ESTA) surged by 24% today, continuing its upward trajectory that began at the onset of the year. Included in the PRISM Women’s Health Index since its inauguration on January 4th, the ...

29 February 2024

Artificial Intelligence:

"LivePerson, Inc. Shares Plummet 42% Following Q4 Loss and Missed Estimates

New York, N.Y., February 29, 2024 - PRISM MediaWire - LivePerson, Inc. (NASDAQ: LPSN) is currently experiencing significant challenges, evident in its impact on the PRISM NextGen Tech & AI Index where it stands as the largest detractor, causing a notable decline of a...

29 February 2024

Enveric Biosciences Makes Strides in Mental Health Treatment, Witnesses 127% Surge in Shares through Out-Licensing of Compound Classes

New York, N.Y., February 29, 2024 - PRISM MediaWire - Enveric Biosciences (NASDAQ: ENVB), a biotechnology firm specializing in the development of neuroplastogenic small-molecule therapeutics for mental health disorders, has announced the initiation of negotiations via th...

29 February 2024

Electric Vehicles

Polestar Automotive Secures $950 Million in Funding Amid Business Plan Progress

New York, N.Y., February 29, 2024 - PRISM MediaWire - Polestar Automotive Holding UK PLC (Nasdaq: PSNY) has recently announced the successful acquisition of $950 million through a three-year loan facility facilitated by a consortium of 12 prominent international banks, w...

29 February 2024

PRISM MarketView

Incannex’s Psilocybin Targets Anxiety with Positive Topline Results

New York, N.Y., February 29, 2024 - PRISM MediaWire - PRISM MarketView - Leading cannabinoid and psychedelic medicine biotechnology company, Incannex Healthcare (Nasdaq: IXHL), has achieved positive topline results in its Phase 2 clinical trial of psilocybin in generali...

29 February 2024

PRISM MarketView

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day

NEW YORK, N.Y., February 29, 2024 - PRISM MediaWire - PRISM MarketView, a leading provider of unbiased market insight and company news, recognizes the remarkable contributions of companies developing treatments for the 10,000 rare diseases affecting more than 30 million ...

29 February 2024